MOG抗体疾病中的新发视力丧失：视神经炎还是中心性浆液性视网膜病变？ - Suppr

Suppr

超能文献

New Onset Visual Loss in MOG Antibody Disease: Optic Neuritis or Central Serous Retinopathy?

作者信息

James Joe, Ravi Sarath

机构信息

Department of Neurology, Malabar Hospitals Eranhipalam, Kerala, India.

Department of Ophthalmology, Sreekanth Eye Care, Kozhikode, Kerala, India.

出版信息

Ann Indian Acad Neurol. 2022 Nov-Dec;25(6):1225-1227. doi: 10.4103/aian.aian_471_22. Epub 2022 Dec 3.

DOI:10.4103/aian.aian_471_22

PMID:36911457

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9996472/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/41ea/9996472/adb685a32a60/AIAN-25-1225-g001.jpg

相似文献

New Onset Visual Loss in MOG Antibody Disease: Optic Neuritis or Central Serous Retinopathy?MOG抗体疾病中的新发视力丧失：视神经炎还是中心性浆液性视网膜病变？

Ann Indian Acad Neurol. 2022 Nov-Dec;25(6):1225-1227. doi: 10.4103/aian.aian_471_22. Epub 2022 Dec 3.

Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series.髓鞘少突胶质细胞糖蛋白（MOG）视神经炎：病例系列

Cureus. 2021 Apr 13;13(4):e14452. doi: 10.7759/cureus.14452.

[Optic neuropathy in positive anti-MOG antibody syndrome].[抗髓鞘少突胶质细胞糖蛋白（MOG）抗体阳性综合征中的视神经病变]

J Fr Ophtalmol. 2019 Dec;42(10):1100-1110. doi: 10.1016/j.jfo.2019.06.006. Epub 2019 Nov 12.

Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.伴有和不伴有髓鞘少突胶质细胞糖蛋白和视神经脊髓炎血清标志物的印度视神经炎患者的临床特征、影像学特征和短期视力结果。

Indian J Ophthalmol. 2022 Jan;70(1):194-200. doi: 10.4103/ijo.IJO_887_21.

Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.髓鞘少突胶质细胞糖蛋白抗体阳性视神经炎：临床特征、放射学线索和结局。

Am J Ophthalmol. 2018 Nov;195:8-15. doi: 10.1016/j.ajo.2018.07.020. Epub 2018 Jul 26.

Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.抗髓鞘少突胶质细胞糖蛋白抗体阳性视神经炎的诊断与治疗

Jpn J Ophthalmol. 2018 Mar;62(2):101-108. doi: 10.1007/s10384-018-0561-1. Epub 2018 Feb 14.

Clinical Profile of Anti-Myelin Oligodendrocyte Glycoprotein Antibody Seropositive Cases of Optic Neuritis.抗髓鞘少突胶质细胞糖蛋白抗体血清阳性视神经炎病例的临床特征

Neuroophthalmology. 2015 Aug 25;39(5):213-219. doi: 10.3109/01658107.2015.1072726. eCollection 2015 Oct.

Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.中国髓鞘少突胶质细胞糖蛋白抗体阳性儿童视神经炎的临床特征和预后。

Br J Ophthalmol. 2019 Jun;103(6):831-836. doi: 10.1136/bjophthalmol-2018-312399. Epub 2018 Jul 26.

Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.中国患者血清阳性髓鞘少突胶质细胞糖蛋白抗体相关性脱髓鞘性视神经炎的临床特征。

Br J Ophthalmol. 2018 Oct;102(10):1372-1377. doi: 10.1136/bjophthalmol-2017-311177. Epub 2018 Jan 23.

Prodromal headache in MOG-antibody positive optic neuritis.MOG 抗体阳性视神经炎的前驱性头痛。

Mult Scler Relat Disord. 2020 May;40:101965. doi: 10.1016/j.msard.2020.101965. Epub 2020 Jan 25.

本文引用的文献

Clinical Course, Imaging Characteristics, and Therapeutic Response in Myelin Oligodendrocyte Glycoprotein Antibody Disease: A Case Series.髓鞘少突胶质细胞糖蛋白抗体病的临床病程、影像学特征及治疗反应：病例系列

J Neurosci Rural Pract. 2020 Jan;11(1):205-210. doi: 10.1055/s-0040-1701371. Epub 2020 Mar 3.

COMPARISON OF SHORT-TERM EFFICACY BETWEEN ORAL SPIRONOLACTONE TREATMENT AND PHOTODYNAMIC THERAPY FOR THE TREATMENT OF NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY.口服螺内酯治疗与光动力疗法治疗未消退中心性浆液性脉络膜视网膜病变的短期疗效比较。

Retina. 2019 Jan;39(1):127-133. doi: 10.1097/IAE.0000000000001913.

Spironolactone versus observation in the treatment of acute central serous chorioretinopathy.螺内酯治疗与观察治疗急性中心性浆液性脉络膜视网膜病变的疗效比较。

Br J Ophthalmol. 2018 Aug;102(8):1060-1065. doi: 10.1136/bjophthalmol-2017-311096. Epub 2017 Oct 31.

Central serous chorioretinopathy and glucocorticoids: an update on evidence for association.中心性浆液性脉络膜视网膜病变与糖皮质激素：关联证据的最新进展

Surv Ophthalmol. 2018 Jan-Feb;63(1):1-8. doi: 10.1016/j.survophthal.2017.06.008. Epub 2017 Jun 30.

Risk of central serous chorioretinopathy in adults prescribed oral corticosteroids: a population-based study in Taiwan.成人使用口服皮质类固醇后发生中心性浆液性脉络膜视网膜病变的风险：一项基于台湾人群的研究。

Retina. 2014 Sep;34(9):1867-74. doi: 10.1097/IAE.0000000000000159.

Central serous chorioretinopathy: a review of epidemiology and pathophysiology.中心性浆液性脉络膜视网膜病变：流行病学和发病机制的综述。

Clin Exp Ophthalmol. 2013 Mar;41(2):201-14. doi: 10.1111/j.1442-9071.2012.02848.x. Epub 2012 Sep 21.

Review and update of central serous chorioretinopathy.中心性浆液性脉络膜视网膜病变的复习与更新。

Curr Opin Ophthalmol. 2011 May;22(3):166-73. doi: 10.1097/ICU.0b013e3283459826.

Risk factors for recurrence of serous macular detachment in untreated patients with central serous chorioretinopathy.未经治疗的中心性浆液性脉络膜视网膜病变患者发生浆液性黄斑脱离复发的危险因素。

Ophthalmic Res. 2011;46(3):160-3. doi: 10.1159/000324599. Epub 2011 Mar 10.

Central serous chorioretinopathy: an update on pathogenesis and treatment.中心性浆液性脉络膜视网膜病变：发病机制和治疗的最新进展。

Eye (Lond). 2010 Dec;24(12):1743-56. doi: 10.1038/eye.2010.130. Epub 2010 Oct 8.

Visual outcome after discontinuation of corticosteroids in atypical severe central serous chorioretinopathy.非典型性严重中心性浆液性脉络膜视网膜病变停用皮质类固醇后的视力转归

Ophthalmology. 2004 Sep;111(9):1708-14. doi: 10.1016/j.ophtha.2004.03.025.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验